Abstract
Sustained JNK activation plays a critical role in hepatotoxicity by acetaminophen or GalN/TNF-α. To address the importance of JNK translocation to mitochondria that accompanies sustained activation in these models, we assessed the importance of the expression of a potential initial target of JNK in the outer membrane of mitochondria, namely Sab (SH3 domain-binding protein that preferentially associates with Btk), also known as Sh3bp5 (SH3 domain-binding protein 5). Silencing the expression of Sab in the liver using adenoviral shRNA inhibited sustained JNK activation and mitochondrial targeting of JNK and the upstream MKK4 (MAPK kinase 4), accompanied by striking protection against liver injury in vivo and in cultured hepatocytes in both toxicity models. We conclude that mitochondrial Sab may serve as a platform for theMAPKpathway enzymes and that the interaction of stress-activated JNK with Sab is required for sustained JNK activation and toxicity. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Win, S., Than, T. A., Han, D., Petrovic, L. M., & Kaplowitz, N. (2011). c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial sab protein expression in mice. Journal of Biological Chemistry, 286(40), 35071–35078. https://doi.org/10.1074/jbc.M111.276089
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.